• No results found

18 results with keyword: 'brcaness predicts resistance containing regimens negative neoadjuvant chemotherapy'

BRCAness Predicts Resistance to Taxane-Containing Regimens in Triple Negative Breast Cancer During Neoadjuvant Chemotherapy

Identifying the BRCAness status can help predict the response to taxane, and changing regimens for BRCAness TNBC might improve patient survival.. A larger prospective study is needed

Protected

N/A

6
0
0
2021
Retention and graduation of Australian Aboriginal and Torres Strait Islander students in initial teacher education

While some teacher education programs had reasonable enrolment of Indigenous students commensurate with the percentage of Indigenous people in their state, the scans

Protected

N/A

6
0
0
2021
Best Practices in PCB Design: Exporting Gerber Files

The Drill and Drill Symbols are created when the Gerber RS-274X is selected and subsequently these files are used in documentation such as the assembly drawing to verify all

Protected

N/A

5
0
0
2021
Why we Need Standards for Breaking the Smart Grid

Systems and Internet Infrastructure Security Laboratory (SIIS) Page Attack Trees Tamper Usage Data Tamper Measure- ment Tamper Stored Demand Tamper in Network Clear Logged

Protected

N/A

19
0
0
2021
Module II. Internet Security. Chapter 7. Intrusion Detection. Web Security: Theory & Applications. School of Software, Sun Yat-sen University

• GIDO (generalized intrusion detection objects). • Event generators • Event analyzers • Event databases • Response units 7.5 Structure of IDS Event Generator Event

Protected

N/A

52
0
0
2021
Nyc Property Lien Search

The New York County Clerk is this office that records mechanics lien claims in New York County, sample are tracing the vomit of possession.. Highlight add text open and

Protected

N/A

21
0
0
2021
Radiation Safety Analysis of Neutron Colimator Based on Nickel Material for Piercing Radial Beamport Utilization of Kartini Research Reactor

Research conducted by Widarto et al, (2014) titled “Current Status of Technology Development and Application of Boron Neu- tron Capture Cancer Therapy With Compact Neutron

Protected

N/A

13
0
0
2021
EU LAW RIGHTS AND NATIONAL REMEDIES: AN UNEASY PARTNERSHIP? DAVID MURRAY (LAW)

The Comet case confirms the national remedial autonomy principle that, in the absence of conferral of a specific EU remedy to accompany an EU right, it is left for the

Protected

N/A

13
0
0
2021
Obtention of tetanus antitoxin hyperimmune sera in equines

For the immunization, the different amounts of immunogen were emulsified in Immune- stimulating oil emulsion and injected according to the several multisite

Protected

N/A

6
0
0
2020
Energy security with a high external dependence: the strategies of Japan and South Korea

However, they have a very high dependence on net energy imports, weighted in terms of the weighting of each source over total consumption (although this is approximately on a par

Protected

N/A

27
0
0
2020
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early

Protected

N/A

12
0
0
2020
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2- positive

Protected

N/A

15
0
0
2020
Characterization of silver resistance in two Gram-positive soil bacteria

Silver resistance in bacteria was first observed in 1975 when the plasmid pMG101 containing a group of genes (designated the sil operon) responsible for silver resistance was

Protected

N/A

112
0
0
2022
HER2-Positive Breast Cancer: Update on New and Emerging Agents

Pertuzumab plus trastuzumab in combination with standard neoadjuvant an- thracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive

Protected

N/A

7
0
0
2021
Creating Tax Alpha B & F Financial Analytics, Inc.

 Tax-exempt payout at death Interest Income Dividend Income Capital Gain Tax Exempt Pension & IRA Real Estate, Roth IRA and. Income Interest Income

Protected

N/A

21
0
0
2021
Optimization of efficient path selection criteria in urban rail transit passenger assignment

Although the kind of quantitative criteria is quite similar in previous literature, the combinations and values are different (table 1). Table 1: The combinations and values of

Protected

N/A

13
0
0
2021
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE) : a phase II, open-label, multicenter, multinational cardiac safety study

plus standard neoadjuvant anthracycline-containing and anthracycline- free chemotherapy regimens in patients with HER2-positive early breast cancer: Efficacy analysis of a phase

Protected

N/A

8
0
0
2021
Hazardous substances in Europe's fresh and marine waters : An overview

Despite the comprehensive suite of legislation now implemented within Europe, the ubiquitous use of chemicals in society represents a major challenge with respect to the

Protected

N/A

67
0
0
2019

Upload more documents and download any material studies right away!